Literature DB >> 16079465

The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins.

Sherifa A Hamed1, Toshitaka Nabeshima.   

Abstract

Neurologists have little concern about the high atherosclerotic risk among epileptics. Recent evidences mount that chronic epilepsy and prolonged use of antiepileptic drugs (AEDs) are associated with multiple risk factors that are critically implicated in pathobiology and dysfunction of the vessel wall through complex molecular mechanisms that promote atherogenesis. This review is concerned with three metabolic alterations, which are attributed as major risk factors for atherosclerosis among epileptics: altered metabolism of a) homocysteine (Hcy), b) lipids and lipoproteins, and c) uric acid. Most conventional AEDs reduce folic acid levels, thereby raising Hcy levels. Hyperhomosysteinemia is recently believed to induce endothelial dysfunction and promote atherosclerosis through complex oxidative and excitatory neurotoxic molecular mechanisms. However, Hcy itself is a convulsing substance with increased seizure recurrence and intractability to antiepileptic medications. AEDs can disturb lipid metabolism with resultant hypercholestrolemia and dyslipidemia, common recognized risks for atherosclerosis. Altered uric acid metabolism is common among epileptics. Uric acid has been implicated in endothelial cell damage and decreased endothelial nitric oxide bioavailability. In the presence of atherosclerotic milieu, uric acid interacts with other substrate toxicities and increased reactive oxygen species, accelerating atherosclerosis. The above information forms the rationale for future routine screening and correction of such metabolic alterations in epileptics. A convincing argument now develops that routine polyvitamin supplementation (folic acid, vitamin B12, vitamin B6, vitamin C, vitamin E, and beta-carotene) becomes increasingly important for women and men receiving AEDs at all ages. The atheroprotective effect of multivitamins is through their antioxidant and anti-inflammatory effects together with their lipid and Hcy lowering effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079465     DOI: 10.1254/jphs.crj05003x

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  7 in total

Review 1.  Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.

Authors:  Bruce Hermann; Michael Seidenberg; Mark Sager; Cynthia Carlsson; Barry Gidal; Raj Sheth; Paul Rutecki; Sanjay Asthana
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

2.  Use of antiepileptic drugs and lipid-lowering agents in the United States.

Authors:  Scott Mintzer; Vittorio Maio; Kathleen Foley
Journal:  Epilepsy Behav       Date:  2014-04-14       Impact factor: 2.937

3.  Atrophy and cognitive profiles in older adults with temporal lobe epilepsy are similar to mild cognitive impairment.

Authors:  Erik Kaestner; Anny Reyes; Austin Chen; Jun Rao; Anna Christina Macari; Joon Yul Choi; Deqiang Qiu; Kelsey Hewitt; Zhong Irene Wang; Daniel L Drane; Bruce Hermann; Robyn M Busch; Vineet Punia; Carrie R McDonald
Journal:  Brain       Date:  2021-02-12       Impact factor: 15.255

4.  Effects of valproate on the carotid artery intima-media thickness in epileptics.

Authors:  Xinming Luo; Ming Zhang; Liying Deng; Jing Zhao
Journal:  Indian J Pharmacol       Date:  2015 Jan-Feb       Impact factor: 1.200

5.  Plasma homocysteine levels associated with a corrected QT interval.

Authors:  Zhao Li; Xiaofan Guo; Guozhe Sun; Liqiang Zheng; Yingxian Sun; Yamin Liu; Maria Roselle Abraham
Journal:  BMC Cardiovasc Disord       Date:  2017-07-11       Impact factor: 2.298

6.  The association between subclinical atherosclerosis and uterine fibroids.

Authors:  Yuan He; Qiang Zeng; Xiaohui Li; Baohua Liu; Peiyu Wang
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

7.  Serum level of homocysteine, folate and vitamin-B12 in epileptic patients under carbamazepine and sodium valproate treatment: a systematic review and meta-analysis.

Authors:  Fazel Gorjipour; Yasin Asadi; Nushin K Osguei; Marjan Effatkhah; Ali Samadikuchaksaraei
Journal:  Iran Red Crescent Med J       Date:  2013-03-05       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.